title: A phase I/II trial of TLR-7 agonist immunotherapy in chronic lymphocytic leukemia.
authors.forename: D E
authors.initials: DE
authors.lastname: Spaner
authors.forename: Y
authors.initials: Y
authors.lastname: Shi
authors.forename: D
authors.initials: D
authors.lastname: White
authors.forename: S
authors.initials: S
authors.lastname: Shaha
authors.forename: L
authors.initials: L
authors.lastname: He
authors.forename: A
authors.initials: A
authors.lastname: Masellis
authors.forename: K
authors.initials: K
authors.lastname: Wong
authors.forename: R
authors.initials: R
authors.lastname: Gorczynski
mesh_terms: D000328:Adult; D000368:Aged; D016207:Cytokines / Q000097:blood; D005260:Female; D006801:Humans; D007167:Immunotherapy; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D051199:Toll-Like Receptor 7 / Q000819:agonists*
chemical_list: D016207:Cytokines; D051199:Toll-Like Receptor 7